Two Sigma Advisers
ELVN icon

Two Sigma Advisers’s Enliven Therapeutics ELVN Stock Holding History

Two Sigma Advisers’s Portfolio ELVN Stock Details ELVN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$105K Buy
2022
Q3 		– Sell
2022
Q2 		$223K Sell
2022
Q1 		$534K Buy
2021
Q4 		$580K Sell
2021
Q3 		$1.06M Buy
2021
Q2 		– Sell
2021
Q1 		$139K Buy